OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Structure-Guided Design of a Domain-Selective Bromodomain and Extra Terminal N-Terminal Bromodomain Chemical Probe
Erin K. Bradley, Lucia Fusani, Chun‐wa Chung, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 23, pp. 15728-15749
Open Access | Times Cited: 6
Erin K. Bradley, Lucia Fusani, Chun‐wa Chung, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 23, pp. 15728-15749
Open Access | Times Cited: 6
Showing 6 citing articles:
An update on lipophilic efficiency as an important metric in drug design
Rebecca A. Gallego, Martin P. Edwards, T. Patrick Montgomery
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 8, pp. 917-931
Closed Access | Times Cited: 2
Rebecca A. Gallego, Martin P. Edwards, T. Patrick Montgomery
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 8, pp. 917-931
Closed Access | Times Cited: 2
Development and Evaluation of [11C]I-58: A Novel PET Radiotracer Targeting BRD4 BD2 for Advanced Epigenetic Imaging
Yanli Wang, Yongle Wang, Yulong Xu, et al.
ACS Omega (2024)
Open Access | Times Cited: 1
Yanli Wang, Yongle Wang, Yulong Xu, et al.
ACS Omega (2024)
Open Access | Times Cited: 1
Discovery of the First BRD4 Second Bromodomain (BD2)-Selective Inhibitors
Junhua Li, Qingqing Hu, Run Zhu, et al.
Journal of Medicinal Chemistry (2024)
Closed Access | Times Cited: 1
Junhua Li, Qingqing Hu, Run Zhu, et al.
Journal of Medicinal Chemistry (2024)
Closed Access | Times Cited: 1
Structure- and Property-Based Optimization of Efficient Pan-Bromodomain and Extra Terminal Inhibitors to Identify Oral and Intravenous Candidate I-BET787
David J. Hirst, Paul Bamborough, Niam Al-Mahdi, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 12, pp. 10464-10489
Closed Access
David J. Hirst, Paul Bamborough, Niam Al-Mahdi, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 12, pp. 10464-10489
Closed Access
Collaborative GSK–University of Strathclyde doctoral research and training programmes: Transforming approaches to industry–academia engagement
Laura C Paterson, P. G. Humphreys, Henry A. Kelly, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 11, pp. 104162-104162
Open Access
Laura C Paterson, P. G. Humphreys, Henry A. Kelly, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 11, pp. 104162-104162
Open Access
The Development and Evaluation of a Novel Highly Selective PET Radiotracer for Targeting BET BD1
Yanli Wang, Yongle Wang, Yulong Xu, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 10, pp. 1289-1289
Open Access
Yanli Wang, Yongle Wang, Yulong Xu, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 10, pp. 1289-1289
Open Access
